This medication helps control HIV infection through a combination of active ingredients. Dolutegravir inhibits the HIV integrase enzyme by binding to its active site, thereby blocking the integration of viral DNA into the host genome and interrupting the replication cycle. Tenofovir and Lamivudine work by incorporating themselves into the viral DNA, inhibiting the reverse transcriptase enzyme and preventing further replication of the virus.